Corporate Neutral

MAXIMA GRUPĖ's Audit Comittee Elected for a New Term

Breaking news from global financial markets

2 weeks ago
Read More
Naujai kadencijai išrinktas MAXIMA GRUPĖS audito komitetas

Naujai kadencijai išrinktas MAXIMA GRUPĖS audito komitetas

Corporate
2 weeks ago 4,525
Read More
FERRARI RENEWS ITS COLLABORATION WITH BITDEFENDER

FERRARI RENEWS ITS COLLABORATION WITH BITDEFENDER

Corporate
2 weeks ago 3,642
Read More
Bang & Olufsen A/S - Transactions in connection with share buyback programme to hedge the company’s share-based incentive programmes

Bang & Olufsen A/S - Transactions in connection with share buyback programme to hedge the company’s share-based incentive programmes

Corporate
2 weeks ago 1,500
Read More
EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU

EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU

Corporate
2 weeks ago 3,442
Read More
Share buyback programme - week 42

Share buyback programme - week 42

Corporate
2 weeks ago 4,889
Read More
Investa Launches Second Crowdcube Raise Following Record-Breaking 2024 Campaign

Investa Launches Second Crowdcube Raise Following Record-Breaking 2024 Campaign

Corporate
2 weeks ago 1,157
Read More
Aktsiaselts Infortar alustab kuni 250 000 oma aktsia tagasiostmist

Aktsiaselts Infortar alustab kuni 250 000 oma aktsia tagasiostmist

Corporate
2 weeks ago 2,041
Read More
Aktsiaselts Infortar to start buy-back of up to 250,000 own shares

Aktsiaselts Infortar to start buy-back of up to 250,000 own shares

Corporate
2 weeks ago 4,915
Read More
Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio

Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio

Corporate
2 weeks ago 3,198
Read More
ST introduces new image sensors for industrial automation, security and retail applications

ST introduces new image sensors for industrial automation, security and retail applications

Corporate
2 weeks ago 1,051
Read More
UAB „Orkela“ sudarė 40 mln. EUR kredito sutartį su SEB banku

UAB „Orkela“ sudarė 40 mln. EUR kredito sutartį su SEB banku

Corporate
2 weeks ago 3,581
Read More
UAB “Orkela” concluded a EUR 40 million credit agreement with SEB Bank

UAB “Orkela” concluded a EUR 40 million credit agreement with SEB Bank

Corporate
2 weeks ago 537
Read More
Roche’s Tecentriq showed significant overall and disease-free survival benefits in bladder cancer with ctDNA-guided treatment

Roche’s Tecentriq showed significant overall and disease-free survival benefits in bladder cancer with ctDNA-guided treatment

Corporate
2 weeks ago 2,194
Read More
FDA approves Roche’s Gazyva/Gazyvaro for the treatment of lupus nephritis

FDA approves Roche’s Gazyva/Gazyvaro for the treatment of lupus nephritis

Corporate
2 weeks ago 3,956
Read More
PSMAddition data show Novartis Pluvicto™ delays progression to end-stage prostate cancer

PSMAddition data show Novartis Pluvicto™ delays progression to end-stage prostate cancer

Corporate
2 weeks ago 4,313
Read More
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025

ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025

Corporate
3 weeks ago 2,674
Read More
AdvanCell’s 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer

AdvanCell’s 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer

Corporate
3 weeks ago 2,129
Read More
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer

Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer

Corporate
3 weeks ago 3,359
Read More
Raw materials for the arms industry – the beginning of vertical integration

Raw materials for the arms industry – the beginning of vertical integration

Corporate
3 weeks ago 2,906
Read More

Trending Now

1

NFL Betting Promos: BetUS' New Customer Bonus for NFL Betting

49,877 40 minutes ago
2

XRP Ledger Reveals Major Smart Contract Milestone: Details

33,611 46 minutes ago
3

Prediction: EV Stocks Will Be Your Best Investment in 2026. Here's Why.

13,738 1 hour ago
4

FAA Orders Grounding of MD-11 Planes After Kentucky Crash

3,307 1 hour ago
5

2 AI Stocks That Could Go Parabolic

33,175 1 hour ago

Trending Topics

Sentiment (24h)

Positive
392
Neutral
114
Negative
98